Oral paclitaxel with encequidar for treating advanced breast cancer [ID5111]
In development
Reference number: GID-TA11022
Expected publication date: TBC
As you will be aware the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of Paclitaxel with encequidar for treating advanced breast cancer.
Please note that following on from advice received from the company the timelines for this appraisal are to be confirmed. Further information regarding the scheduling of this appraisal will be available in due course.